Vertex Pharmaceuticals, Inc. (VRTX)
461.19
+19.11
(+4.32%)
USD |
NASDAQ |
Jan 21, 16:00
460.98
-0.21
(-0.05%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap: 117.01B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 147.32B |
| Amgen, Inc. | 185.01B |
| Eli Lilly & Co. | 967.01B |
| Merck & Co., Inc. | 275.73B |
| Alnylam Pharmaceuticals, Inc. | 48.27B |
Market Cap Related Metrics
| PE Ratio | 32.50 |
| PS Ratio | 10.18 |
| Price to Book Value | 6.756 |
| Price to Free Cash Flow | 35.81 |
| Price | 461.19 |
| Earnings Yield | 3.08% |
| Operating PE Ratio | 26.39 |
| Normalized PE Ratio | 29.47 |